Validation of two predictive models for survival in anaplastic thyroid cancer (ATC)
The SPI was more accurate than the MCPS to determine patients' life expectancies and should be recommended for clinical guidance and treatment allocation. In the last decade, comprehensive genetic profiling of actionable mutations in ATC has become vital to guide targeted therapy.
Authors
- Alexander Nieto
- Claus Belka (ORCID: https://orcid.org/0000-0002-1287-7825)
- Teresa Augustin
- Marie A. Neu (ORCID: https://orcid.org/0000-0002-8564-7115)
- Dmytro Oliinyk (ORCID: https://orcid.org/0009-0000-7662-2189)
- Christine Spitzweg (ORCID: https://orcid.org/0000-0002-0413-9697)
- Viktoria Florentine Koehler (ORCID: https://orcid.org/0000-0002-2665-1181)
- Lukas Käsmann (ORCID: https://orcid.org/0000-0002-4372-3597)
- Josefine Rauch
- Robert Rennollet
- Ralph Gurtner
Institutions
- German Cancer Research Center (DE)
- University Hospital Augsburg (DE)
- TUM Klinikum (DE)
- LMU Klinikum (DE)
- University Hospital Regensburg (DE)
- Mayo Clinic in Florida (US)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1186/s12885-024-13217-2
- Citations
- 2
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.72